Abstract:1 Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 2 Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea 3 Department of Family Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 4 Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea 5 Department of Family Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea Copyright © 2024 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Download PDF CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported. AUTHOR CONTRIBUTIONS Conception or design: K.S., Y.J.K. Acquisition, analysis, or interpretation of data: all authors. Drafting the work or revising: K.S., Y.J.K. Final approval of the manuscript: all authors. FUNDING This work was supported by the Korea Evaluation Institute of Industrial Technology (KEIT) grant funded by the Korean government (MOTIE) (20018384). Values are presented as mean±standard error. IR, insulin resistance; ALT, alanine aminotransferase; SDS, standard deviation score; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; AST, aspartate aminotransferase; HOMA-IR, homeostasis model assessment of insulin resistance; METS-IR, the metabolic score for insulin resistance; TyG, triglyceride-glucose index; SPISE, single-point insulin sensitivity estimator. Logistic regression analyses were performed with IR and ALT elevation as dependent variables. IR, insulin resistance; ALT, alanine aminotransferase; OR, odds ratio; CI, confidence interval; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; METS-IR, the metabolic score for insulin resistance; TyG, triglyceride-glucose index; SPISE, single-point insulin sensitivity estimator. AUC, area under the receiver operating characteristic curve; IR, insulin resistance; ALT, alanine aminotransferase; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; METS-IR, the metabolic score for insulin resistance; TyG, triglyceride-glucose index; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; SPISE, single-point insulin sensitivity estimator; HOMA-IR, homeostasis model assessment of insulin resistance. Values are presented as mean±standard error. IR, insulin resistance; ALT, alanine aminotransferase; SDS, standard deviation score; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; AST, aspartate aminotransferase; HOMA-IR, homeostasis model assessment of insulin resistance; METS-IR, the metabolic score for insulin resistance; TyG, triglyceride-glucose index; SPISE, single-point insulin sensitivity estimator. Values are presented as mean±standard error. IR, insulin resistance; ALT, alanine aminotransferase; SDS, standard deviation score; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; AST, aspartate aminotransferase; HOMA-IR, homeostasis model assessment of insulin resistance; METS-IR, the metabolic score for insulin resistance; TyG, triglyceride-glucose index; SPISE, single-point insulin sensitivity estimator. Logistic regression analyses were performed with IR and ALT elevation as dependent variables. IR, insulin resistance; ALT, alanine aminotransferase; OR, odds ratio; CI, confidence interval; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; METS-IR, the metabolic score for insulin resistance; TyG, triglyceride-glucose index; SPISE, single-point insulin sensitivity estimator. Logistic regression analyses were performed with IR and ALT elevation as dependent variables. IR, insulin resistance; ALT, alanine aminotransferase; OR, odds ratio; CI, confidence interval; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; METS-IR, the metabolic score for insulin resistance; TyG, triglyceride-glucose index; SPISE, single-point insulin sensitivity estimator. AUC, area under the receiver operating characteristic curve; IR, insulin resistance; ALT, alanine aminotransferase; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; METS-IR, the metabolic score for insulin resistance; TyG, triglyceride-glucose index; TG, triglyceride; HDL-C, high-density lipoprotein choleste -Abstract Truncated-

The single point insulin sensitivity estimator (SPISE) is associated with bone health in Arab adults

Association of single‐point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes

The single point insulin sensitivity estimator (SPISE) index as a predictor of metabolic syndrome in Korean adults

Single point insulin sensitivity estimator index for identifying metabolic syndrome in US adults: NHANES 2017-march 2020

Bone metabolism and insulin resistance in obese children

Association between single-point insulin sensitivity estimator and heart failure in older adults: A cross-sectional study

Association of insulin resistance with near peak bone mass in the femur and lumbar spine of Korean adults aged 25-35: The Korean National Health and Nutrition Examination Survey 2008-2010

ASSOCIATION BETWEEN SINGLE POINT INSULIN SENSITIVITY ESTIMATE AND METABOLIC PHENOTYPE IN CHINESE ADOLESCENTS AGED 12–18 YEARS OLD

Influence of Insulin-Like Growth Factor Binding Protein (IGFBP)-1 and IGFBP-3 on Bone Health: Results from the European Male Ageing Study

Bone Turnover Biomarkers in Obese Postmenopausal Saudi Women with Type-Ii Diabetes Mellitus.

Association between insulin resistance and bone mass in men

Role of Hyperglycaemia in the Relationship Between Serum Osteocalcin Levels and Relative Skeletal Muscle Index.

Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait

1441-P: Correlation of Serum Osteocalcin Levels and Relative Skeletal Muscle Index and Hyperglycaemia in a Cohort of Middle-Aged and Elderly Individuals

Association between serum insulin-like growth factor-1 and bone mineral density in patients with type 2 diabetes

Serum Uric Acid Level Is Positively Associated With Higher Bone Mineral Density at Multiple Skeletal Sites Among Healthy Qataris

Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients

Comparison of SPISE and METS-IR and Other Markers to Predict Insulin Resistance and Elevated Liver Transaminases in Children and Adolescents

The Association Between The Serum C-Peptide Level And Bone Mineral Density

Association between dietary insulin index and postmenopausal osteoporosis in Iranian women: a case-control study

Does ethnicity influence bone health index in children? A pilot study